[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"University of Ontario Institute of Technology\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":50},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":32,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":5},"100652333","liberalizing-potassium-restrictions-in-patients-receiving-hemodialysis-100652333",false,"NCT07772856","Liberalizing Potassium Restrictions in Patients Receiving Hemodialysis","Evaluating the Safety and Acceptability of a Liberalized Potassium Diet in Maintenance Hemodialysis Recipients: A Randomized Controlled Trial (LIBERATE K-HD)","LIBERATE-K HD","Inclusion Criteria\n\n1. Age ≥18 years on maintenance HD \\>3 months\n2. ≥1 serum potassium concentration \\>5.0 mmol\u002FL on routine bloodwork in past 12 months\n3. Able to provide consent\n\nExclusion Criteria\n\n1. Treatment with potassium binders within the preceding 7 days\n2. Average Urea reduction rate over the past 3 months \\\u003C65%\n3. \\>2 missed scheduled dialysis sessions in the previous month\n4. Patients receiving \\\u003C3 hemodialysis sessions per week (ex\u002F incremental dialysis)\n5. Average serum potassium concentration \\>6.0 mmol\u002FL over the past 3 months\n6. Swallowing difficulties or other GI issues preventing adequate intake\n7. Residing in an institutional setting (e.g., Long-term care homes) where meals are provided\n8. HbA1c \\>11%\n9. Unable to comply with study procedures due to cognitive impairment, language barrier or for any additional reason specified by the attending clinician","ALL","18 Years",{"count":20,"type":21},148,"ESTIMATED","INTERVENTIONAL",[24],"NA","People with end-stage kidney disease who receive hemodialysis are often told to strictly limit foods high in potassium, such as fruits, vegetables, legumes, nuts, and whole grains. This advice is intended to prevent high blood potassium levels (hyperkalemia), which can cause dangerous heart rhythm problems. However, these restrictions can make eating difficult, reduce diet quality, and lower quality of life. New research suggests that not all sources of potassium affect the body in the same way. Potassium added to highly processed foods is more easily absorbed than potassium naturally found in whole foods like fruits and vegetables. Large studies have found little evidence that eating potassium-rich whole foods increases blood potassium levels in people on dialysis. Clinical guidelines are beginning to shift, but no high-quality clinical trial has tested whether a more flexible, food-based approach is safe for people receiving hemodialysis. This study will compare two dietary approaches in 148 adults on hemodialysis: the usual low potassium diet and a \"liberalized\" potassium diet that encourages minimally processed foods while limiting highly processed foods with potassium additives. Participants will receive dietitian support and grocery assistance for 12 weeks. The investigators will closely monitor blood potassium levels to ensure safety. The investigators will also examine whether the liberalized diet is as safe as standard care, and whether it improves diet quality and quality of life. The investigators will also study factors that influence the participant's ability to follow the diet in real-world settings. If safe, this approach could reduce unnecessary food restrictions, improve diet quality, and enhance quality of life for people receiving hemodialysis, while maintaining patient safety.",[27,28,29,30,31],"End Stage Kidney Disease (ESKD)","Hemodialysis","Diet Intervention","Hyperkalemia","Potassium Bioavailability",[33,34,35,36,37],"end stage kidney disease","hemodialysis","diet intervention","hyperkalemia","potassium bioavailability","NOT_YET_RECRUITING","2026-08-13",{"date":41,"type":42},"2026-08-19","ACTUAL",{"date":44,"type":21},"2026-08-01",{"date":46,"type":21},"2030-09-01",{"name":48,"class":49},"University of Ontario Institute of Technology","OTHER",""]